INTERNATIONAL TRADE LAW
Importing Pharmaceuticals: FDA Rules Explained
To import a prescription drug into the U.S., the drug generally must be FDA-approved, the establishments behind it registered and the product listed, and — once in distribution — it must move through the traceability system the Drug Supply Chain Security Act requires. Pharmaceuticals are among the most tightly controlled imports there are, because the default rule is prohibition: an unapproved new drug cannot lawfully enter. This guide explains the core requirements and the traps that most often stop a shipment.
The Default Rule: Unapproved New Drugs Cannot Enter
Start from the baseline. The Federal Food, Drug, and Cosmetic Act prohibits the interstate shipment — which includes importation — of unapproved new drugs. The practical consequence is blunt: importing a new drug that lacks FDA approval generally violates the Act, whether the drug is for resale or personal use. A drug that is legally sold abroad, or even a foreign version of a drug approved here, is still an unapproved new drug in the U.S. if that specific product has not been approved by the FDA.
There is a narrow personal-importation practice under which the FDA may exercise enforcement discretion case-by-case — for example, for a serious condition with no effective treatment available domestically — but it is a limited exception, not a commercial import pathway. Commercial importers should plan around the approval requirement, not the exception.
Approval, Registration, and Listing
Three things have to be true for a commercial drug import to be lawful.
| Requirement | What it means |
|---|---|
| FDA approval | The drug is covered by an approved application (such as an NDA, ANDA, or BLA) or another lawful pathway. |
| Establishment registration | Drug manufacturers and certain other establishments register with the FDA. |
| Drug listing | The specific drug product is listed with the FDA. |
Approval is product-specific and the highest hurdle. Generic drugs reach the market through an Abbreviated New Drug Application showing equivalence to a reference product; biologics go through a Biologics License Application. Active pharmaceutical ingredients, finished drugs, and over-the-counter products each have their own rules, so the first compliance question is always: what exactly am I importing, and what is its U.S. regulatory status? For a step-by-step view, see our overview of how to import pharmaceuticals.
DSCSA: Traceability Through the Supply Chain
Once a prescription drug is lawfully in U.S. distribution, the Drug Supply Chain Security Act (DSCSA) governs how it moves. Enacted in 2013, the DSCSA builds an electronic, interoperable system to trace prescription drugs through the supply chain and to verify product at the unit level, so that suspect or illegitimate product can be identified and removed.
The enhanced, unit-level tracing requirements phased in through late 2025 — with staggered deadlines for manufacturers, wholesale distributors, and dispensers, and a remaining exemption for small dispensers extending into late 2026. As of 2026, the enhanced requirements are in effect for most trading partners. Importers and their U.S. distribution partners should confirm where they sit in the trading-partner definitions and ensure their systems exchange the required transaction data.
Customs Still Applies — and So Do Controlled-Substance Rules
Drug imports clear customs on the normal track: entry, bond, classification, valuation, and origin, as covered in our general import-compliance guide. FDA review runs alongside the CBP process and gates release. If the product is a controlled substance, a separate and stricter regime applies under the Drug Enforcement Administration, including registration and import permits — those requirements are in addition to, not instead of, the FDA rules.
Where Pharmaceutical Imports Go Wrong
The recurring failure points are predictable: importing a product that simply is not FDA-approved; establishment registration or drug listing that is missing or mismatched at entry; relying on the personal-importation exception for what is really a commercial shipment; and overlooking DSCSA or controlled-substance obligations downstream. Each of these can convert a routine shipment into a detained — or refused — one.
FAQ
Can I import a cheaper version of an FDA-approved drug from abroad? Generally no. Even a foreign-made version of a U.S.-approved drug is treated as an unapproved new drug unless that specific product is itself approved. Price is not the test; approval is.
Does personal importation let me bring in medication for myself? Only in narrow circumstances under FDA enforcement discretion, not as a reliable or commercial pathway. It is an exception, and the FDA can still refuse the product.
What is the difference between approval and registration? Approval is product-specific clearance that a drug is safe and effective for its use. Registration and listing are administrative steps identifying the establishment and the product — they do not substitute for approval.
Do DSCSA rules apply to importers? If you are a trading partner handling prescription drugs in U.S. distribution, the DSCSA framework applies to your transactions. Confirm your role and your data-exchange obligations.
Importing pharmaceuticals into the U.S.? Reidel Law Firm delivers a flat-fee Import/Export Compliance Memo — a plain-English read on your product’s approval status, registration and listing, DSCSA exposure, and entry requirements, with direct attorney access. Get a flat-fee compliance memo →
